Klaas Nico Faber
Publications by Year
Research Areas
Inflammatory Bowel Disease, Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms, Microscopic Colitis, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases(2019)3,569 cited
- → Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases(2019)508 cited
- → How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?(2021)394 cited
- → Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease(2020)370 cited
- → Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump(2002)286 cited
- → Highly-efficient electrotransformation of the yeast Hansenula polymorpha(1994)271 cited
- → Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)(2017)223 cited
- → Drug transport proteins in the liver(2003)220 cited
- → The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut(2017)187 cited
- → LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process(2004)178 cited